CEO Robert Marshall, Jr. was excited to share some news regarding The F-Tranzacts Group. "We are thrilled to announce that we have further expanded our funding space in California's pharmaceutical sector. Recently, a pharmaceutical company in California has successfully secured an impressive $64MM in funding. This substantial amount will serve two key purposes: refinancing existing debt and strengthening their working capital. As you know, the healthcare industry can be highly competitive, and having a solid financial foundation will help to navigate this landscape more effectively," said the CEO.

"We remain committed to providing top-quality healthcare solutions and services to our valued customers. This funding will undoubtedly enhance our ability to expand and innovate within the industry while maintaining our focus on delivering exceptional healthcare. We are a returning client to The F-Tranzacts Group, I must commend the professionalism of the team that lead to a quick closing," said Jacqueline, VP. Oak Healthcare, California branch.